Abstract
Short-term effects of cholic acid ingestion on hepatic accumulation, fecal excretion, and blood levels of protoporphyrin were studied in vivo in griseofulvin-induced protoporphyric mice. Experimental mice that received feed with 2% griseofulvin and 0.5% cholic acid were compared with control mice that received feed with 2% griseofulvin for 4 wk. Five mice from each group were assessed each week for liver and blood porphyrin levels. Fecal protoporphyrin was compared weekly in the total pooled output of each population. Mean protoporphyrin levels were significantly lower for liver (P less than 0.0001), erythrocytes (P less than 0.05), and plasma (P less than 0.05), and higher for feces (P less than 0.001) for the mice that were fed cholic acid. Microscopic protoporphyrin deposits, inflammation, necrosis, and dysplasia were more severe in livers of control mice. A second experimental design compared four regimens in the feed given to all mice after 1-wk induction with 2% griseofulvin: (a) 0.5% cholic acid, (b) no adulterant, (c) 2% griseofulvin and 0.5% cholic acid, and (d) 2% griseofulvin. No difference in protoporphyrin removal from livers of mice in groups 1 and 2 was observed after 1 and 2 wk of these regimens. The apparent reduction in hepatic protoporphyrin content in mice of group 3 as compared with group 4 at weeks 2 and 3 was not significant at P less than 0.05. These data suggest that in selected circumstances, hepatic protoporphyrin secretion may be enhanced in protoporphyric disease states by bile salt supplementation.
Full text
PDF









Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Avner D. L., Berenson M. M. Effect of choleretics on canalicular transport of protoporphyrin in the rat liver. Am J Physiol. 1982 Apr;242(4):G347–G353. doi: 10.1152/ajpgi.1982.242.4.G347. [DOI] [PubMed] [Google Scholar]
- Barnes H. D., Hurworth E., Millar J. H. Erythropoietic porphyrin hepatitis. J Clin Pathol. 1968 Mar;21(2):157–159. doi: 10.1136/jcp.21.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bechtel M. A., Bertolone S. J., Hodge S. J. Transfusion therapy in a patient with erythropoietic protoporphyria. Arch Dermatol. 1981 Feb;117(2):99–101. [PubMed] [Google Scholar]
- Bloomer J. R. Pathogenesis and therapy of liver disease in protoporphyria. Yale J Biol Med. 1979 Jan-Feb;52(1):39–48. [PMC free article] [PubMed] [Google Scholar]
- Bloomer J. R., Phillips M. J., Davidson D. L., Klatskin G., Bloomer Hepatic disease in erythropoietic protoporphyria. Am J Med. 1975 Jun;58(6):869–882. doi: 10.1016/0002-9343(75)90644-0. [DOI] [PubMed] [Google Scholar]
- Bloomer J. R., Pierach C. A. Effect of hematin administration to patients with protoporphyria and liver disease. Hepatology. 1982 Nov-Dec;2(6):817–821. doi: 10.1002/hep.1840020613. [DOI] [PubMed] [Google Scholar]
- Bonkowsky H. L., Bloomer J. R., Ebert P. S., Mahoney M. J. Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts. J Clin Invest. 1975 Nov;56(5):1139–1148. doi: 10.1172/JCI108189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cripps D. J., Goldfarb S. S. Erythropoietic protoporphyria: hepatic cirrhosis. Br J Dermatol. 1978 Mar;98(3):349–354. doi: 10.1111/j.1365-2133.1978.tb06163.x. [DOI] [PubMed] [Google Scholar]
- Cripps D. J., Scheuer P. J. Hepatobiliary changes in erythropoietic protoporphyria. Arch Pathol. 1965 Nov;80(5):500–508. [PubMed] [Google Scholar]
- DE MATTEIS F., RIMINGTON C. Disturbance of porphyrin metabolism caused by griseofulvin in mice. Br J Dermatol. 1963 Mar;75:91–104. doi: 10.1111/j.1365-2133.1963.tb13945.x. [DOI] [PubMed] [Google Scholar]
- DeLeo V. A., Poh-Fitzpatrick M., Mathews-Roth M., Harber L. C. Erythropoietic protoporphyria. 10 years experience. Am J Med. 1976 Jan;60(1):8–22. doi: 10.1016/0002-9343(76)90528-3. [DOI] [PubMed] [Google Scholar]
- Donaldson E. M., McCall A. J., Magnus I. A., Simpson J. R., Caldwell R. A., Hargreaves T. Erythropoietic protoporphyria: two deaths from hepatic cirrhosis. Br J Dermatol. 1971 Jan;84(1):14–24. doi: 10.1111/j.1365-2133.1971.tb14191.x. [DOI] [PubMed] [Google Scholar]
- Gschnait F., Konrad K., Hönigsmann H., Denk H., Wolff K. Mouse model for protoporphyria. I. The liver and hepatic protoporphyrin crystals. J Invest Dermatol. 1975 Sep;65(3):290–299. doi: 10.1111/1523-1747.ep12598357. [DOI] [PubMed] [Google Scholar]
- Ibrahim G. W., Watson C. J. Enterohepatic circulation and conversion of protoporphyrin to bile pigment in man. Proc Soc Exp Biol Med. 1968 Mar;127(3):890–895. doi: 10.3181/00379727-127-32829. [DOI] [PubMed] [Google Scholar]
- Klatskin G., Bloomer J. R. Birefringence of hepatic pigment deposits in erythropoietic protoporphyria. Specificity of polarization microscopy in the identification of hepatic protoporphyrin deposits. Gastroenterology. 1974 Aug;67(2):294–302. [PubMed] [Google Scholar]
- Lamon J. M., Poh-Fitzpatrick M. B., Lamola A. A. Hepatic protoporphyrin production in human protoporphyria. Effects of intravenous hematin and analysis of erythrocyte protoporphyrin distribution. Gastroenterology. 1980 Jul;79(1):115–125. [PubMed] [Google Scholar]
- Lefkowitch J. H., Feng-Chen K. C., Sklar J. A., Poh-Fitzpatrick M. B. Cholic acid amelioration of light and electron microscopic hepatic lesions in experimental protoporphyria. Hepatology. 1983 May-Jun;3(3):399–406. doi: 10.1002/hep.1840030319. [DOI] [PubMed] [Google Scholar]
- MacDonald D. M., Germain D., Perrot H. The histopathology and ultrastructure of liver disease in erythropoietic protoporphyria. Br J Dermatol. 1981 Jan;104(1):7–17. doi: 10.1111/j.1365-2133.1981.tb01705.x. [DOI] [PubMed] [Google Scholar]
- Macdonald D. M., Nicholson D. C. Erythropoietic protoporphyria. Hepatic implications. Br J Dermatol. 1976 Aug;95(2):157–162. doi: 10.1111/j.1365-2133.1976.tb00819.x. [DOI] [PubMed] [Google Scholar]
- Matilla A., Molland E. A. A light and electron microscopic study of the liver in case of erythrohepatic protoporphyria and in griseofulvin-induced porphyria in mice. J Clin Pathol. 1974 Sep;27(9):698–709. doi: 10.1136/jcp.27.9.698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakao K., Wada O., Takaku F., Sassa S., Yano Y., Urata G. The origin of the increased protoporphyrin in erythrocytes of mice with experimentally induced porphyria. J Lab Clin Med. 1967 Dec;70(6):923–932. [PubMed] [Google Scholar]
- Piomelli S. A micromethod for free erythrocyte porphyrins: the FEP test. J Lab Clin Med. 1973 Jun;81(6):932–940. [PubMed] [Google Scholar]
- Piomelli S., Lamola A. A., Poh-Fitzpatrick M. F., Seaman C., Harber L. C. Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. I. Different rates of disappearance of protoporphyrin from the erythrocytes, both in vivo and in vitro. J Clin Invest. 1975 Dec;56(6):1519–1527. doi: 10.1172/JCI108233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Poh-Fitzpatrick M. B., Lamola A. A. Comparative study of protoporphyrins in erythropoietic protoporphyria and griseofulvin-induced murine protoporphyria. Binding affinities, distribution, and fluorescence spectra in various blood fractions. J Clin Invest. 1977 Aug;60(2):380–389. doi: 10.1172/JCI108787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scholnick P., Marver H. S., Schmid R. Erythropoietic protoporphyria: evidence for multiple sites of excess protoporphyrin formation. J Clin Invest. 1971 Jan;50(1):203–207. doi: 10.1172/JCI106474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shah V. P., Riegelman S., Epstein W. L. Determination of griseofulvin in skin, plasma, and sweat. J Pharm Sci. 1972 Apr;61(4):634–636. doi: 10.1002/jps.2600610434. [DOI] [PubMed] [Google Scholar]
- Wells M. M., Golitz L. E., Bender B. J. Erythropoietic protoporphyria with hepatic cirrhosis. Arch Dermatol. 1980 Apr;116(4):429–432. [PubMed] [Google Scholar]



